While these symptoms are often temporary, understanding why they happen and how to ease them is key to staying on track with your treatment
Most clinical protocols suggest starting tirzepatide first at the lowest dose (0.25 mg weekly for semaglutide-equivalent strength, or 2.5 mg weekly for tirzepatide), tolerating it for 4 weeks, then introducing NAD+ supplementation (typically 250500 mg daily via oral NMN or NR) once nausea or GI side effects stabilize
Membership access and prescribing authority are separated , with the platform handling billing and coordination and clinicians controlling eligibility and medication decisions
Keywords: glucagon-like peptide-1 receptor agonists, inflammatory bowel disease, Crohns disease, ulcerative colitis 1
Agric Res 9(2):179187 Tommasini R, Martinoia E, Grill E, Dietz KJ, Amrhein N (1993) Transport of oxidized glutathione into barley vacuoles evidence for the involvement of the glutathione-S-conjugate ATPase